ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
11 announcements with these filters
Promoter Chemikas Speciality LLP pledged 10,87,500 shares of Archean Chemical Industries as loan collateral on 17 Sept 2026. Total encumbered holding rose to 30.53% of the company.
Chemikas Speciality LLP created a pledge on 30,000 shares of Archean Chemical Industries Limited as collateral for loans.
SBI Mutual Fund sold 1,47,599 shares of Archean Chemical Industries Ltd, representing 0.1196% of the company's equity, via market sale on September 03, 2026.
Archean Chemical reported Q1 FY27 consolidated revenue of INR 3,328.1M, up 10.7% YoY. Standalone margins improved to 25.3%, with bromine derivatives business turning EBITDA positive for the first time.
Archean reported Q1FY27 consolidated revenue of ₹3,328 Mn, up 11% YoY. Strategy focuses on bromine derivatives, semiconductors via SiCSem, and energy storage through Offgrid Energy Labs.
Archean Chemical Industries Ltd reported revenue from operations of ₹327.2 Cr (+11.9% YoY) and net profit of ₹30.4 Cr (-24.2% YoY) for Q1 FY27.
Chemikas Speciality LLP released the pledge on 5,200 shares of Archean Chemical Industries Ltd. The release occurred after repaying the loan availed.
Archean Chemical Industries submitted its Reconciliation of Share Capital Audit Report for the quarter ended June 30, 2026, as required by SEBI regulations.
Archean Chemical Industries has scheduled a board meeting for July 30, 2026, to approve the company's un-audited financial results for the quarter ended June 30, 2026.
Archean Chemical Industries clarified that recent trading volume spikes are purely market-driven. The company confirmed no undisclosed price-sensitive information exists.
Archean Chemical's investee, Offgrid Energy Labs, inaugurated a 10 MWh Zinc Bromide battery pilot facility in the UK. This marks a transition toward commercial-scale production synergy.